This special report argues that many patients with chronic pain may not be significantly impacted by psychological factors, and that for those who are, cognitive–behavioral therapy is the treatment of choice.
In this editorial, the authors discuss the building body of evidence for the role of cortical spreading depression in migraine headache, as well as the further investigation required into this relationship.
This article reviews the targeting of CGRP, a biomarker of migraine, as a treatment for the disorder and efforts to develop mechanism-based therapies.
Peter Goadsby discusses his extensive research in headache disorders, including the pathophysiology of headaches, rare forms and research needs within the field.
This article discusses the feasibility of combining SNP associations in order to predict individual risk of migraine.
The American Academy of Neurology (AAN) have released new guidelines for the treatment of spasticity, cervical dystonia, blepharospasm and migraine with botulinum toxin at their annual meeting in Vancouver (15 – 21st April, Vancouver, BC, Canada).
For World Alzheimer’s Month we talked to Gabriel Vargas about his current research in Alzheimer’s and other neurological conditions.
We will describe the pharmacokinetic profile, clinical efficacy and safety data of the sumatriptan iontophoretic…
This editorial discusses the use of botulinum neurotoxin A in preventing headaches in adult patients with chronic migraine.